AR
Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
$14.74 -4.35% (-$0.67)
1M +96.01%
Market Cap $419.0M
P/E Ratio -
Div. Yield -
ROE 46.54%
Piotroski F-Score Weak
1/9Valuation
39 /100
Fair P/S 17.60x
P/B 2.44x
P/E N/A
Growth
0 /100
Declining Rev. growth 31.13%
Book val. growth 7.49%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 83.19%
Net margin 391.90%
FCF margin 306.91%
Quality
1 /100
Poor ROIC 52.96%
ROE 46.54%
Asset turnover 0.11x
Debt
100 /100
Low Debt/Equity 0.13x
Current ratio 5.88x
Int. coverage N/A
Stability
18 /100
Unstable Beta 2.27x
Rev. volatility 20.19%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ARCT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph E. Payne
Employees
109
Headquarters
San Diego
Evenimente viitoare
09 NOV.
Earnings
Upcoming earnings report